Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

An Investment in IonQ Is a Sign of Faith in the Scale of Next-Gen Computers

Although IONQ stock is risky due to its underlying novel technologies, the upside potential is extraordinarily massive.

Why Tilray Investors Shouldn’t Bet on the U.S. Legalizing Marijuana

While the federal legalization of cannabis is a commonly cited potential catalyst for TLRY stock, investors shouldn’t count on it.

7 Sharing Economy Stocks to Buy as the Pandemic Changes Work

With digitalization increasingly inspiring people to get away from their cubicles, these sharing economy stocks could benefit.

Use Logic, Not Clichés When Analyzing Your Next Move With Ethereum

While the rise in Ethereum is incredibly enticing, it pays for prospective ETH-USD investors to step aside and take a breather.

Digital World Acquisition Is a Perfect Play on Online Anger

While anger is usually a poor business ethos, for DWAC stock, it’s the one emotion that could make shares a smash hit.

7 New Stocks That Can Provide Long-Term Gains After Their IPOs

With 2021 proving to be the year of compelling IPOs, here are some new stocks to consider if you’re feeling in a risk-on mood.

QuantumScape Stock Is Starting to Look More Credible for the Speculator

While QS stock still carries significant risk, its underlying technology got a credibility boost, making speculation worth considering.

Massive Jump Is a Great Selling Opportunity For Novavax Stock

Although NVAX stock has recently been bolstered by good news, it may not be enough to overcome vaccine disinformation.

7 European Stocks to Buy to Diversify Your Portfolio

While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks.

7 Meme Cryptos to Buy for Gamblers Tired of the Stock Market

Have you gotten bored of safe, traditional investments and want to do something daring? These meme cryptos to buy might be enticing to you.